Phase 1/2 Study of VELCADE® in Combination With Other Drugs to Treat Previously Untreated Multiple Myeloma Patients
Clinical trial NCT00507442 · COMPLETED
Trial details
- NCT number
- NCT00507442
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2010-10-01
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.